Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.66 |
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.50 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 11/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43995 | 1.00 | FOLH1 (0.66) | FOLH1GSRSLC6A5RNPEPCA1 | |
| SCHEMBL9875634 | 1.00 | FOLH1 (0.66) | FOLH1GSRSLC6A5RNPEPCA1 | |
| Pyrrole SCHEMBL28847693 | 0.88 | FOLH1 (0.54) | FOLH1GSRSLC6A5RNPEPCA1 | |
| SCHEMBL24141430 | 0.88 | FOLH1 (0.54) | FOLH1GSRSLC6A5RNPEPCA1 | |
| SCHEMBL12572609 | 0.88 | FOLH1 (0.83) | FOLH1GSRSLC6A5RNPEPCPB2 | |
| SCHEMBL1006179 | 0.86 | FOLH1 (0.64) | FOLH1GSRSLC6A5RNPEPCA1 | |
| SCHEMBL1006178 | 0.86 | FOLH1 (0.64) | FOLH1GSRSLC6A5RNPEPCA1 | |
| SCHEMBL5497824 | 0.86 | FOLH1 (0.64) | FOLH1GSRSLC6A5RNPEPCA1 | |
| SCHEMBL30109129 | 0.86 | FOLH1 (0.50) | FOLH1GSRSLC6A5RNPEPCA1 | |
| SCHEMBL20530 | 0.84 | FOLH1 (0.62) | FOLH1GSRSLC6A5RNPEPCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116376947-A | Method suitable for screening bacterial strain with high yield of non-protein amino acid | 北京理工大学 | 2023-07-04 | — | — | CN | claimed |
| US-20210138117-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2021-05-13 | — | — | US | claimed |
| US-10874766-B2 | Compounds and matrices for use in bone growth and repair | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2020-12-29 | — | — | US | claimed |
| US-9474292-B1 | Nutritional powder including brewer's yeast, aronia extract, and cranberry extract for animals | EvoSci Biotech LLC (US) | 2016-10-25 | — | — | US | claimed |
| US-20160038641-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2016-02-11 | — | — | US | claimed |
| EP-1858352-B1 | A COMPOSITION COMPRISING A POWDER CONTAINING MICROENCAPSULATED POLYUNSATURATED LONG-CHAIN ESTERIFIED FATTY ACIDS DISTRIBUTED IN AN EFFERVESCENT BASE | DELANTE HEALTH AS (NO) | 2013-06-05 | — | — | EP | claimed |
| US-20080279935-A1 | Composition Comprising a Powder Containing Microencapsulated Polyunsaturated Long-Chain Esterified Fatty Acids Distributed in an Effervescent Base | SWG INVEST AS (NO) | 2008-11-13 | — | — | US | claimed |
| EP-1858352-A1 | A COMPOSITION COMPRISING A POWDER CONTAINING MICROENCAPSULATED POLYUNSATURATED LONG-CHAIN ESTERIFIED FATTY ACIDS DISTRIBUTED IN AN EFFERVESCENT BASE | Core Competence Sweden AB (SE) | 2007-11-28 | — | — | EP | claimed |
| WO-2006088418-A1 | A COMPOSITION COMPRISING A POWDER CONTAINING MICROENCAPSULATED POLYUNSATURATED LONG-CHAIN ESTERIFIED FATTY ACIDS DISTRIBUTED IN AN EFFERVESCENT BASE | CORE COMPETENCE SWEDEN AB (SE) | 2006-08-24 | — | — | WO | claimed |
| US-6811793-B2 | TABLET THAT INCLUDES STEVIA, WATER SOLUBLE BINDER, WATER SOLUBLE LUBRICANT, ACTIVE AGENT, AND EFFERVESCENT AGENT. | AMERILAB TECHNOLOGIES, INC. | 2004-11-02 | — | — | US | claimed |
| US-20030170301-A1 | Effervescent composition including stevia | AMERILAB TECHNOLOGIES, INC. | 2003-09-11 | — | — | US | claimed |
| EP-3445343-B1 | COMPOSITION AND METHOD FOR PRETREATING CANCER | VALCURIA AB (SE) | 2026-02-25 | — | — | EP | disclosed |
| EP-4114865-B1 | PROTEASE-PROCESSED MOLECULES | SANOFI SA (FR) | 2026-01-28 | — | — | EP | disclosed |
| US-20250302915-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE DAMAGE AND ARTHRITIS | NOVARTIS AG (CH) | 2025-10-02 | — | — | US | disclosed |
| US-20250171512-A1 | FGF21 VARIANTS | SANOFI SA (FR) | 2025-05-29 | — | — | US | disclosed |
| US-5480652-A | HAVING IMPROVED STABILITY | LABORATOIRES UPSA (FR) | 1996-01-02 | — | — | US | disclosed |
| EP-0673245-A1 | EFFERVESCENT PHARMACEUTICAL COMPOSITION CONTAINING IBUPROFEN AND METHOD FOR PREPARING SAME. | UNION PHARMA SCIENT APPL (FR) | 1995-09-27 | — | — | EP | disclosed |
| US-5437874-A | Water soluble salt or complex of acetylsalicylic acid with metoclopramide or salt, stabilized with hydrophilic polymer | LABORATOIRES UPSA (FR) | 1995-08-01 | — | — | US | disclosed |
| WO-1995014462-A1 | NOVEL PHARMACEUTICAL COMPOSITION FOR THE PREPARATION OF A STABLE POWDER CONTAINING AN ACTIVE PRINCIPLE COMPRISING AN ASSOCIATION OF ACETYLSALICYLIC ACID AND METOCLOPRAMIDE | LABORATOIRES UPSA (FR) | 1995-06-01 | — | — | WO | disclosed |
| WO-1994013279-A1 | EFFERVESCENT PHARMACEUTICAL COMPOSITION CONTAINING IBUPROFEN AND METHOD FOR PREPARING SAME | LABORATOIRES UPSA (FR) | 1994-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10874766-B2 | Compounds and matrices for use in bone growth and repair | BMP2, BMP4, BMP6 | FOLH1 2457/4885GSR 4119/4885SLC6A5 3389/4885 |
| US-20210138117-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | BMP2, BMP4, BMP6 | FOLH1 2115/4885GSR 3778/4885SLC6A5 3212/4885 |
| US-20160038641-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | BMP2, BMP4, BMP6 | FOLH1 2676/4885GSR 4244/4885SLC6A5 3856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.